ArticlePeerJ2022
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer.
Ming Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticlePeerJ2022
Ming Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.